Back

PCSK9,LDL regulation and inflammation.

27 August 2017 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: Lipids in atherosclerosis - Evolving concepts Lipids ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Dimitris Tousoulis

University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
HDL/LDL and vascular remodelling.
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
HDL/LDL and cardiac remodelling.
Doctor G. Vilahur (Barcelona, ES)
Slides Video
Presentation thumbnail
Lp(a) and cardiovascular disease.
Professor S. Tsimikas (La Jolla, US)
Slides Video

Access the full session

Session thumbnail
Lipids in atherosclerosis - Evolving concepts

The Event

Event poster

ESC Congress 2017

27 August 2017 11:45 CET
You may be interested in
thumbnail
Congress Presentation
The effect of proprotein convertase subtilisin/kexin type 9 inhibition on the plasma proteome: a SPIRE sub-study
28 August 2023
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
20 June 2025
thumbnail
Congress Presentation
Comparing coronary artery plaque regression in patients treated with ezetimibe or PCSK9 inhibitors following acute coronary syndrome: a systematic review and meta-analysis
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources